The effect of moderate weight loss on a non-invasive biomarker of liver fibrosis: a randomised controlled trial
<p><strong>Background:</strong> Referral to weight loss programmes is the only effective treatment for non-alcoholic fatty liver disease (NAFLD). Clinicians should advise weight loss and screen for liver fibrosis using the Enhanced Liver Fibrosis (ELF) score. </p> <p>&l...
| Главные авторы: | , , , |
|---|---|
| Формат: | Journal article |
| Язык: | English |
| Опубликовано: |
Karger Publishers Open Access
2020
|